Circulating MicroRNAs and Clinical Parameters in Hypertrophic Cardiomyopathy: A Systematic Review and Correlation Meta-Analysis
Frontiers in Bioscience-Scholar · 09.06.2026 · 18 (2)
DOI: 10.31083/fbs47633 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Bioscience-Scholar, online erschienen am 09.06.2026. Verfasst von Antonio da Silva Menezes Junior und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Federal University of Goiás, Goiânia, GO 74605-050, Brazil. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Circulating MicroRNA, MicroRNAs. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hypertrophic cardiomyopathy (HCM) is genetically heterogeneous and characterized by left ventricular hypertrophy, myocardial fibrosis, and diverse clinical manifestations. Although circulating microRNAs (miRNAs) are promising biomarkers of pathological cardiac remodeling, the correlation of these miRNAs with specific clinical characteristics of HCM remains unclear. Therefore, we systematically reviewed and quantified the correlation between circulating miRNAs and structural and functional cardiac parameters in HCM.
Methods
This systematic review and meta-analysis of observational studies evaluated the association between circulating miRNA expression levels and Echocardiography, magnetic resonance imaging, and histological parameters for HCM. We comprehensively searched the PubMed, Embase, Scopus, and Web of Science databases, and extracted and transformed correlation coefficients into Fisher’s Z-scores. The study was registered with PROSPERO under registration number CRD420251058653. Meta-analyses were conducted using random-effects models, and heterogeneity was assessed using the I2 statistic. Sensitivity analyses, meta-regression, and publication bias were also assessed.
Results
A total of 11 studies comprising 633 patients were included. Pooled analysis showed moderate-to-strong positive correlations between miRNAs (miR-21, miR-29a, miR-199a-5p, and miR-27a) and myocardial fibrosis, wall thickness, and left ventricular mass (r = 0.53; 95% confidence interval 0.40–0.64; I2 = 60.1%). Sensitivity and meta-regression analyses confirmed the robustness of the results, with no significant publication bias. The risk-of-bias assessment (Quality Assessment of Diagnostic Accuracy Studies 2) revealed moderate concerns, primarily related to patient selection and index-test blinding.
Conclusion
Circulating miRNAs were significantly correlated with structural and functional cardiac changes in HCM, supporting the potential role of these miRNAs as noninvasive biomarkers. However, further high-quality studies are needed to validate their clinical applicability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Federal University of Goiás, Goiânia, GO 74605-050, Brazil.
- Medical Department, Medical Sciences and Life School, Pontifical Catholic University of Goiás, Goiânia, GO 74605-050, Brazil.
Zitieren
APA
Menezes Junior, A. D. S., de Oliveira, H. L., & de Lima, K. B. A. (2026). Circulating MicroRNAs and Clinical Parameters in Hypertrophic Cardiomyopathy: A Systematic Review and Correlation Meta-Analysis. Frontiers in Bioscience-Scholar, 18(2). https://doi.org/10.31083/fbs47633
Vancouver
Menezes Junior ADS, de Oliveira HL, de Lima KBA. Circulating MicroRNAs and Clinical Parameters in Hypertrophic Cardiomyopathy: A Systematic Review and Correlation Meta-Analysis. Frontiers in Bioscience-Scholar. 2026;18(2). doi:10.31083/fbs47633
BibTeX
@article{MenezesJunior2026,
author = {Menezes Junior, Antonio da Silva and de Oliveira, Henrique Lima and de Lima, Khissya Beatryz Alves},
title = {Circulating MicroRNAs and Clinical Parameters in Hypertrophic Cardiomyopathy: A Systematic Review and Correlation Meta-Analysis},
journal = {Frontiers in Bioscience-Scholar},
year = {2026},
volume = {18},
number = {2},
doi = {10.31083/fbs47633}
}
EUVIMED